01 22Pfizer Canada Inc.
01 42071875
02 92124690
03 92202875
01 22Moroctocog Alfa
01 22Powder for Solution
01 42010-12-06
02 92013-10-01
03 92015-11-14
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Brand Name : XYNTHA
Patent Number : 2071875
Filing Date : 1990-12-06
Strength per Unit : 250 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Brand Name : XYNTHA
Patent Number : 2124690
Filing Date : 1993-10-01
Strength per Unit : 250 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Brand Name : XYNTHA
Patent Number : 2071875
Filing Date : 1990-12-06
Strength per Unit : 500 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Brand Name : XYNTHA
Patent Number : 2124690
Filing Date : 1993-10-01
Strength per Unit : 500 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Brand Name : XYNTHA
Patent Number : 2071875
Filing Date : 1990-12-06
Strength per Unit : 1000 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Brand Name : XYNTHA
Patent Number : 2124690
Filing Date : 1993-10-01
Strength per Unit : 1000 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Brand Name : XYNTHA
Patent Number : 2071875
Filing Date : 1990-12-06
Strength per Unit : 2000 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2010-12-06
Date Granted : 2006-08-08
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Brand Name : XYNTHA
Patent Number : 2124690
Filing Date : 1993-10-01
Strength per Unit : 2000 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Brand Name : XYNTHA SOLOFUSE
Patent Number : 2124690
Filing Date : 1993-10-01
Strength per Unit : 250 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2013-10-01
Date Granted : 2007-09-11
Patent Expiration Date : 2015-11-14
Date Granted : 2011-03-15
Brand Name : XYNTHA
Patent Number : 2202875
Filing Date : 1995-11-14
Strength per Unit : 250 IU
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous Infusion
Patent Expiration Date : 2015-11-14
Date Granted : 2011-03-15
